Oxytocin antagonists (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameOxytocin antagonists (Pfizer)
Drug Alias NamePF-2721374PF-534422UK-451402PF-271836PF-383965 +[8] 
ClassificationSmall molecules
Mechanisms of ActionOxytocin receptor antagonistsReproductive system modulators
TargetsOxytocin receptor
Therapy Area/IndicationsObstetric Labor, PrematureSexual Dysfunction, PhysiologicalProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsObstetric Labor, PrematureSexual Dysfunction, PhysiologicalProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A